ProfileGDS5822 / ILMN_2505360
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 1% 50% 5% 55% 20% 20% 47% 6% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 15.11
GSM1276600PDAC Late Ablation Control 224.450
GSM1276601PDAC Late Ablation Control 3
GSM1276602PDAC Late Ablation 17.15
GSM1276603PDAC Late Ablation 226.455
GSM1276604PDAC Late Ablation 311.920
GSM1303940PDAC Late Ablation_anti-CTLA4 112.720
GSM1303941PDAC Late Ablation_anti-CTLA4 222.947
GSM1303942PDAC Late Ablation_anti-CTLA4 34.86